Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Adv Funct Mater
Both are easy to add to a routine lab order
BPC-157 and TB-500 operate via distinct but complementary mechanisms BPC-157 primarily through growth factor receptor upregulation and angiogenesis, TB-500 through actin-mediated cell migration and cytoskeletal remodelling
Ensacove, an orally available tyrosine kinase inhibitor, addresses ALK-positive NSCLC by disrupting ALK-mediated signaling, in turn blocking the hyperactive growth and proliferation typical of cancer cells
US$ 20.39
US$ 28.31
US$ 23.81
US$ 20.14
